We recently published 10 Stocks With Easy 20-40% Gains. Avidity Biosciences, Inc. (NASDAQ:RNA) is one of the last week’s best-performing stocks. Avidity Biosciences climbed by 42.1 percent ...

The first sprayable insecticide made of RNA can target and kill ravenous Colorado potato beetles while sparing most ...

Diagnosing heart failure in women can be particularly challenging. New research on biomarkers may lead to more accurate ...

The deal, which Novartis expects can “unlock multibillion-dollar opportunities” in the years ahead, hands the company a group ...

Benitec Biopharma Inc. (NASDAQ: BNTC) (“Benitec” or the “Company”), a clinical-stage, gene therapy-focused, biotechnology company developing novel genetic medicines based on its proprietary “Silence ...

Cells contain a blueprint in the form of DNA that dictates what they can make. This blueprint is converted into a message ...

The observation that mRNA vaccines can sensitize tumors to immunotherapy has researchers eager to test how mRNA’s ability to activate the immune system could be harnessed in oncology.

Novartis is buying Avidity Biosciences for $12 billion, picking up RNA-based medicines for neuromuscular diseases as it seeks ...

Researchers fhave created a new type of drug molecule that can precisely destroy TERRA, an RNA molecule that helps certain ...

Messenger RNA (mRNA) therapeutics hold significant promise for the future of personalized cancer treatment, but persistent off-target effects and treatment-resistant tumor microenvironments have ...

A new study published in Nature Biotechnology shows that stem cell differentiation is linked to cellular structures called ...

The University at Albany and Virginia Commonwealth University were awarded a $6.5 million NIH grant to establish a federal ...